Navigation Links
Blending conference translates substance abuse research into practice
Date:4/16/2012

Experts will share the latest clinical research with addiction treatment professionals, healthcare providers, policy makers, and others during the April 19th Blending Conference in Atlanta, Georgia. The program is supported by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, in collaboration with the American Society of Addiction Medicine Annual Medical-Scientific Conference as part of an ongoing initiative to accelerate research findings into practice.

WHAT: Blending Initiative: Accelerating Knowledge Exchange in Substance Abuse Treatment
www.seiservices.com/nida/blending2012/Default.aspx

WHEN: April 19, 2012
8 a.m. 5 p.m.

WHERE: Hilton Atlanta Hotel
255 Courtland St. NE
Atlanta, GA 30303

This year's program includes:

  • Making motivational interviewing techniques accessible to primary care;
  • New approaches to pharmacotherapy for substance use disorders;
  • Screening, brief intervention, referral to treatment (SBIRT): implementation for primary care and/or emergency departments; and
  • HIV testing and intervention in integrated treatment settings.


'/>"/>

Contact: NIDA Press Office
media@nida.nih.gov
301-443-6245
NIH/National Institute on Drug Abuse
Source:Eurekalert

Page: 1

Related medicine news :

1. Custom Blending Announces New Brand Launch: Harmony Valley Vegetarian Mixes at Fancy Food Show, New York City, June 27-29, 2010
2. NJ stroke researchers report advances in spatial neglect research at AAN Conference
3. Elsevier organizes label-free technologies conference
4. Conference explores ethical dimension of NHS
5. Kessler Foundation neuroscientist addresses 2nd Annual TBI Conference in Washington DC
6. Kessler Foundation researchers present at DC Conference on Race, Ethnicity and Disabilities
7. Experts in pediatric heart disease present research at Cardiology 2012 conference
8. TGen hosts international conference for leading pediatric cancer researchers, foundations
9. SFU hits hot buttons at 2012 AAAS conference
10. Global conference on stem cell therapy for heart disease to be held Jan. 25-27 in NYC
11. Kessler Foundations John DeLuca, Ph.D., conducts national MS Society teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators are used to treat ... if one isn’t accessible in certain locations, the risk of death can be ... with this idea," said an inventor from Ridgecrest, Calif. , The MOBILE AUTOMATED ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... SABRE Safe Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student from ... in Educational Leadership and Administration at St. Thomas University in Miami, Florida, was ...
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... and more products at customers’ doorstep. According to Smart Mart, customers can now ... stated to offer wearable, and customers can find clothing at discounted prices. Apart ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for Medical ... p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device manufacturing ... The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a warning ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), ... partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry technology ... leading mobile spirometry platform and Novartis, commitment to address the ... ... ...
(Date:9/6/2017)... 6, 2017  Robert G. Szewc, M.D., is recognized ... in recognition of his contributions to the Medical field.  ... Nephrologist at the practice of Kidney and Hypertension Specialists, ... and hypertension solutions. He has worked in this position ... experience, as well as expertise in kidneys, hypertension, chronic ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
Breaking Medicine Technology: